AbbVie (ABBV) said Wednesday its upadacitinib oral therapy for adults with moderate to severe Crohn's disease showed "significantly higher" endoscopic...
CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as...
(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...
(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...
Health care stocks were mostly lower this afternoon, with the NYSE Health Care Index sinking 2.0% and the SPDR Health Care Select Sector ETF (XLV) down...
AbbVie (ABBV) said Friday that the Food and Drug Administration has approved the use of Rinvoq to treat adults with active ankylosing spondylitis, an...
AbbVie's (ABBV) stock price dropped more than 8% in Friday afternoon trading after the drugmaker lowered its full-year profit outlook while its Q2 guidance...
Health care stocks were mostly lower this afternoon, with the NYSE Health Care Index sinking 1.7% and the SPDR Health Care Select Sector ETF (XLV) down...
Health care stocks were mostly lower this afternoon, with the NYSE Health Care Index sinking 1.7% while the SPDR Health Care Select Sector ETF (XLV) was...
AbbVie (ABBV) on Friday cut its full-year profit outlook and outlined second-quarter guidance that missed Wall Street's estimates after the drugmaker's...